547 related articles for article (PubMed ID: 31932947)
21. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.
Franceschi J; Ehret M; Visseaux L; Durlach A; Barbe C; Durot É; Grange F
Acta Derm Venereol; 2022 Mar; 102():adv00676. PubMed ID: 35083494
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous lymphomas.
Smith BD; Wilson LD
Semin Radiat Oncol; 2007 Jul; 17(3):158-68. PubMed ID: 17591562
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous T-cell lymphoma (mycosis fungoides).
Lorincz AL
Lancet; 1996 Mar; 347(9005):871-6. PubMed ID: 8622396
[No Abstract] [Full Text] [Related]
24. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
25. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
26. Paediatric cutaneous lymphomas: a review and comparison with adult counterparts.
Kempf W; Kazakov DV; Belousova IE; Mitteldorf C; Kerl K
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1696-709. PubMed ID: 25715748
[TBL] [Abstract][Full Text] [Related]
27. Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy.
Kamijo H; Miyagaki T
Curr Treat Options Oncol; 2021 Jan; 22(2):10. PubMed ID: 33415447
[TBL] [Abstract][Full Text] [Related]
28. Mycosis fungoides and Sézary syndrome.
Jonak C; Tittes J; Brunner PM; Guenova E
J Dtsch Dermatol Ges; 2021 Sep; 19(9):1307-1334. PubMed ID: 34541796
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of indolent cutaneous B‑cell lymphoma].
Wobser M
Hautarzt; 2017 Sep; 68(9):721-726. PubMed ID: 28766120
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
31. [Quality of life of patients with mycosis fungoides and Sézary syndrome].
Jäger M; Özistanbullu D; Klemke CD; Tratzmiller S
Dermatologie (Heidelb); 2022 Oct; 73(10):759-764. PubMed ID: 36074143
[TBL] [Abstract][Full Text] [Related]
32. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; Wilcox RA
Am J Hematol; 2023 Jan; 98(1):193-209. PubMed ID: 36226409
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous lymphomas: exploration of 10-year data from supraregional mutlidisciplinary team meetings in Glasgow, UK.
McCusker S; Ngu I
Clin Exp Dermatol; 2023 Aug; 48(9):1036-1039. PubMed ID: 37140442
[TBL] [Abstract][Full Text] [Related]
35. [Cutaneous lymphomas].
Ingen-Housz-Oro S; Bagot M
Rev Prat; 2009 Nov; 59(9):1207-15. PubMed ID: 19961071
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous lymphomas in adolescents and young adults: Clinical spectrum and physician-reported and patient-reported outcomes.
Delost GR; Giesey RL; Christensen LF; Scott J; Cooper KD
J Am Acad Dermatol; 2020 Mar; 82(3):751-753. PubMed ID: 31400457
[No Abstract] [Full Text] [Related]
37. [Mycosis fungoides and Sézary syndrome : a systematic review].
André F; Guenova E; Blanchard G
Rev Med Suisse; 2022 Mar; 18(775):578-589. PubMed ID: 35353453
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; A Wilcox R
Am J Hematol; 2021 Oct; 96(10):1313-1328. PubMed ID: 34297414
[TBL] [Abstract][Full Text] [Related]
40. [Cutaneous lymphomas].
Schad K; Baumann Conzett K; Cozzio A
Ther Umsch; 2010 Sep; 67(9):453-64. PubMed ID: 20806174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
